FDG PET/MR for the Assessment of Lymph Node Involvement in Lymphoma: Initial Results and Role of Diffusion-Weighted MR

被引：18

作者：

Platzek, Ivan ^{[1
]}

Beuthien-Baumann, Bettina ^{[2
]}

Ordemann, Rainer ^{[3
]}

Maus, Jens ^{[4
]}

Schramm, Georg ^{[4
]}

Kitzler, Hagen H. ^{[5
]}

Laniado, Michael ^{[1
]}

Kotzerke, Joerg ^{[2
]}

van den Hoff, Joerg ^{[4
]}

机构：

[1] Dresden Univ Hosp, Dept Radiol, D-01307 Dresden, Germany

[2] Dresden Univ Hosp, Dept Nucl Med, D-01307 Dresden, Germany

[3] Dresden Univ Hosp, Dept Internal Med, D-01307 Dresden, Germany

[4] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dresden, Germany

[5] Dresden Univ Hosp, Dept Neuroradiol, D-01307 Dresden, Germany

来源：

ACADEMIC RADIOLOGY | 2014年 / 21卷 / 10期

关键词：

Lymphoma; PET/MR; staging; sensitivity; specificity; POSITRON-EMISSION-TOMOGRAPHY; PERFORMANCE; CONSENSUS;

D O I：

10.1016/j.acra.2014.05.019

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Rationale and Objectives: The purpose of this study was to evaluate the sensitivity and specificity of positron emission tomography/magnetic resonance imaging (PET/MR) with 18F-fluorodeoxyglucose (FDG) for nodal involvement in malignant lymphoma. Materials and Methods: Twenty-seven patients with malignant lymphoma (16 men and 11 women; mean age, 45 years) were included in this retrospective study. The patients underwent FDG PET/MR after intravenous injection of FDG (176-357 MBq FDG, 282 MBq on average). Follow-up imaging and histology served as the standard of reference. Results: One-hundred and twenty-seven (18.1%) of 702 lymph node stations were rated as having lymphoma-involvement based on the standard of reference. One-hundred and twenty-four (17.7%) of 702 lymph node stations were rated as positive by FDG PET/MR. The sensitivity and specificity of FDG PET/MR for lymph node station involvement were 93.8% and 99.4%. Conclusions: FDG PET/MR is feasible for lymphoma staging and has a high-sensitivity and specificity for nodal involvement in lymphoma. Comparison with PET/CT is necessary to determine whether FDG PET/MR can replace PET/CT for lymphoma staging.

引用

页码：1314 / 1319

页数：6

共 20 条

[1] FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 [J].

Boellaard, Ronald ;

O'Doherty, Mike J. ;

Weber, Wolfgang A. ;

Mottaghy, Felix M. ;

Lonsdale, Markus N. ;

Stroobants, Sigrid G. ;

Oyen, Wim J. G. ;

Kotzerke, Joerg ;

Hoekstra, Otto S. ;

Pruim, Jan ;

Marsden, Paul K. ;

Tatsch, Klaus ;

Hoekstra, Corneline J. ;

Visser, Eric P. ;

Arends, Bertjan ;

Verzijlbergen, Fred J. ;

Zijlstra, Josee M. ;

Comans, Emile F. I. ;

Lammertsma, Adriaan A. ;

Paans, Anne M. ;

Willemsen, Antoon T. ;

Beyer, Thomas ;

Bockisch, Andreas ;

Schaefer-Prokop, Cornelia ;

Delbeke, Dominique ;

Baum, Richard P. ;

Chiti, Arturo ;

Krause, Bernd J. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) :181-200

[2] Consistency of FDG-PET Accuracy and Cost-Effectiveness in Initial Staging of Patients With Hodgkin Lymphoma Across Jurisdictions [J].

Cerci, Juliano J. ;

Trindade, Evelinda ;

Buccheri, Valeria ;

Fanti, Stefano ;

Coutinho, Artur M. N. ;

Zanoni, Lucia ;

Linardi, Camila C. G. ;

Celli, Monica ;

Delbeke, Dominique ;

Pracchia, Luis F. ;

Pitela, Felipe A. ;

Soares, Jose, Jr. ;

Zinzani, Pier Luigi ;

Meneghetti, Jose C. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (04) :314-320

[3]

Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726

[4] Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group [J].

Eich, HT ;

Staar, S ;

Gossmann, A ;

Hansemann, K ;

Skripnitchenko, R ;

Kocher, M ;

Semrau, R ;

Engert, A ;

Josting, A ;

Franklin, J ;

Krug, B ;

Diehl, V ;

Müller, RP .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04) :1121-1127

[5] FDG-PET/CT in re-staging of patients with lymphoma [J].

Freudenberg, LS ;

Antoch, G ;

Schütt, P ;

Beyer, T ;

Jentzen, W ;

Müller, SP ;

Görges, R ;

Nowrousian, MR ;

Bockisch, A ;

Debatin, JF .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (03) :325-329

[6] Initial staging of lymphoma with positron emission tomography and computed tomography [J].

Hicks, RJ ;

Mac Manus, MP ;

Seymour, JF .

SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (03) :165-175

[7]

Hutchings M, 2006, HAEMATOLOGICA, V91, P482

[8] Cancer statistics, 2007 [J].

Jemal, Ahmedin ;

Siegel, Rebecca ;

Ward, Elizabeth ;

Murray, Taylor ;

Xu, Jiaquan ;

Thun, Michael J. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66

[9] Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma [J].

Juweid, Malik E. ;

Stroobants, Sigrid ;

Hoekstra, Otto S. ;

Mottaghy, Felix M. ;

Dietlein, Markus ;

Guermazi, Ali ;

Wiseman, Gregory A. ;

Kostakoglu, Lale ;

Scheidhauer, Klemens ;

Buck, Andreas ;

Naumann, Ralph ;

Spaepen, Karoline ;

Hicks, Rodney J. ;

Weber, Wolfgang A. ;

Reske, Sven N. ;

Schwaiger, Markus ;

Schwartz, Lawrence H. ;

Zijlstra, Josee M. ;

Siegel, Barry A. ;

Cheson, Bruce D. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :571-578

[10] Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG [J].

Leide-Svegborn, S. .

RADIATION PROTECTION DOSIMETRY, 2010, 139 (1-3) :208-213

← 1 2 →